APA

Gauvreau G. M., Becker A. B., Boulet L., Chakir J., Fick R. B., Greene W. L., Killian K. J., O'byrne P. M., Reid J. K. & Cockcroft D. W. (20030905). The effects of an anti-CD11a mAb, efalizumab, on allergen-induced airway responses and airway inflammation in subjects with atopic asthma. : The Journal of allergy and clinical immunology.

Chicago

Gauvreau Gail M, Becker Allan B, Boulet Louis-Philippe, Chakir Jamila, Fick Robert B, Greene William L, Killian Kieran J, O'byrne Paul M, Reid John K and Cockcroft Donald W. 20030905. The effects of an anti-CD11a mAb, efalizumab, on allergen-induced airway responses and airway inflammation in subjects with atopic asthma. : The Journal of allergy and clinical immunology.

Harvard

Gauvreau G. M., Becker A. B., Boulet L., Chakir J., Fick R. B., Greene W. L., Killian K. J., O'byrne P. M., Reid J. K. and Cockcroft D. W. (20030905). The effects of an anti-CD11a mAb, efalizumab, on allergen-induced airway responses and airway inflammation in subjects with atopic asthma. : The Journal of allergy and clinical immunology.

MLA

Gauvreau Gail M, Becker Allan B, Boulet Louis-Philippe, Chakir Jamila, Fick Robert B, Greene William L, Killian Kieran J, O'byrne Paul M, Reid John K and Cockcroft Donald W. The effects of an anti-CD11a mAb, efalizumab, on allergen-induced airway responses and airway inflammation in subjects with atopic asthma. : The Journal of allergy and clinical immunology. 20030905.